MCID: DYS021
MIFTS: 39

Dysautonomia

Categories: Blood diseases, Neuronal diseases, Rare diseases

Aliases & Classifications for Dysautonomia

MalaCards integrated aliases for Dysautonomia:

Name: Dysautonomia 53 29 54 6 71

Classifications:



External Ids:

UMLS 71 C0013363

Summaries for Dysautonomia

NINDS : 53 Dysautonomia refers to a disorder of autonomic nervous system (ANS) function that generally involves failure of the sympathetic or parasympathetic components of the ANS, but dysautonomia involving excessive or overactive ANS actions also can occur. Dysautonomia can be local, as in reflex sympathetic dystrophy, or generalized, as in pure autonomic failure. It can be acute and reversible, as in Guillain-Barre syndrome, or chronic and progressive. Several common conditions such as diabetes and alcoholism can include dysautonomia. Dysautonomia also can occur as a primary condition or in association with degenerative neurological diseases such as Parkinson's disease. Other diseases with generalized, primary dysautonomia include multiple system atrophy and familial dysautonomia. Hallmarks of generalized dysautonomia due to sympathetic failure are impotence (in men) and a fall in blood pressure during standing (orthostatic hypotension). Excessive sympathetic activity can present as hypertension or a rapid pulse rate.

MalaCards based summary : Dysautonomia is related to fatal familial insomnia and parkinson disease 1, autosomal dominant. An important gene associated with Dysautonomia is USH2A (Usherin). The drugs Propranolol and Neurotransmitter Agents have been mentioned in the context of this disorder. Affiliated tissues include heart, testes and brain.

Wikipedia : 74 Dysautonomia or autonomic dysfunction is a condition in which the autonomic nervous system (ANS) does... more...

Related Diseases for Dysautonomia

Diseases in the Dysautonomia family:

Dysautonomia-Like Disorder

Diseases related to Dysautonomia via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 427)
# Related Disease Score Top Affiliating Genes
1 fatal familial insomnia 32.1 SNCA PRNP
2 parkinson disease 1, autosomal dominant 32.0 SNCA GBA
3 parkinson disease, late-onset 30.9 SNCA PRNP GBA DNAJC13
4 rem sleep behavior disorder 29.8 SNCA GBA
5 amyloidosis, hereditary, transthyretin-related 29.8 SNCA PRNP
6 tremor 29.5 SNCA GBA DNAJC13
7 supranuclear palsy, progressive, 1 29.4 SNCA PRNP GBA
8 chronic pain 29.2 USH2A CPT2
9 neuropathy, hereditary sensory and autonomic, type iii 12.7
10 hypotonia, hypoventilation, impaired intellectual development, dysautonomia, epilepsy, and eye abnormalities 12.6
11 dysautonomia-like disorder 12.4
12 acute cholinergic dysautonomia 12.4
13 motor neuropathy, peripheral, with dysautonomia 12.3
14 insensitivity to pain, congenital, with anhidrosis 12.1
15 pure autonomic failure 12.1
16 autonomic dysfunction 12.0
17 hereditary sensory neuropathy 12.0
18 stuve-wiedemann syndrome 11.6
19 neuropathy, hereditary sensory and autonomic, type iia 11.4
20 achalasia-addisonianism-alacrima syndrome 11.4
21 primary orthostatic hypotension 11.4
22 autonomic nervous system disease 11.3
23 neuropathy, hereditary sensory and autonomic, type vi 11.2
24 scoliosis, isolated 1 11.1
25 occipital horn syndrome 11.1
26 neurodegeneration with brain iron accumulation 3 11.1
27 nescav syndrome 11.1
28 rigidity and multifocal seizure syndrome, lethal neonatal 11.1
29 parkinson disease 23, autosomal recessive early-onset 11.1
30 autoimmune autonomic ganglionopathy 11.1
31 autoimmune gastrointestinal dysmotility 11.1
32 morvan's fibrillary chorea 11.1
33 autonomic neuropathy 10.5
34 neuropathy 10.5
35 autosomal recessive disease 10.5
36 guillain-barre syndrome 10.4
37 constipation 10.4
38 syncope 10.4
39 multiple system atrophy 1 10.4
40 sensory peripheral neuropathy 10.3
41 dysphagia 10.3
42 scoliosis 10.3
43 polyneuropathy 10.3
44 brain injury 10.3
45 traumatic brain injury 10.3
46 ataxia and polyneuropathy, adult-onset 10.3
47 orthostatic intolerance 10.3
48 peripheral nervous system disease 10.3
49 diarrhea 10.3
50 sleep apnea 10.2

Graphical network of the top 20 diseases related to Dysautonomia:



Diseases related to Dysautonomia

Symptoms & Phenotypes for Dysautonomia

Drugs & Therapeutics for Dysautonomia

Drugs for Dysautonomia (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 78)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Propranolol Approved, Investigational Phase 4 525-66-6 4946
2 Neurotransmitter Agents Phase 4
3 Adrenergic Agents Phase 4
4 Adrenergic beta-Antagonists Phase 4
5 Antihypertensive Agents Phase 4
6 Adrenergic Antagonists Phase 4
7 Vasodilator Agents Phase 4
8 Anti-Arrhythmia Agents Phase 4
9
Dopamine Approved Phase 3 51-61-6, 62-31-7 681
10
Carbidopa Approved Phase 3 28860-95-9 34359
11
Ipratropium Approved, Experimental Phase 3 60205-81-4, 22254-24-6 43232 657309
12 Aromatic Amino Acid Decarboxylase Inhibitors Phase 3
13 Dopamine Agents Phase 3
14 Adrenergic beta-Agonists Phase 3
15 Respiratory System Agents Phase 3
16 Cholinergic Agents Phase 3
17 Albuterol Phase 3
18 Adrenergic Agonists Phase 3
19 Cholinergic Antagonists Phase 3
20 Bronchodilator Agents Phase 3
21 Anti-Asthmatic Agents Phase 3
22 Bromides Phase 3
23 Tocolytic Agents Phase 3
24 Anti-Inflammatory Agents Phase 3
25
Norepinephrine Approved Phase 2 51-41-2 439260
26
Verapamil Approved Phase 2 52-53-9 2520
27
Carvedilol Approved, Investigational Phase 2 72956-09-3 2585
28
Methylprednisolone Approved, Vet_approved Phase 2 83-43-2 6741
29
Prednisolone phosphate Approved, Vet_approved Phase 2 302-25-0
30
Methylprednisolone hemisuccinate Approved Phase 2 2921-57-5
31
Cyclophosphamide Approved, Investigational Phase 2 50-18-0, 6055-19-2 2907
32
Prednisolone Approved, Vet_approved Phase 2 50-24-8 5755
33 Prednisolone acetate Approved, Vet_approved Phase 2 52-21-1
34
Baclofen Approved Phase 2 1134-47-0 2284
35
Vitamin A Approved, Nutraceutical, Vet_approved Phase 2 22737-96-8, 68-26-8, 11103-57-4 9904001 445354
36
Prednisolone hemisuccinate Experimental Phase 2 2920-86-7
37 Pharmaceutical Solutions Phase 2
38 Antioxidants Phase 2
39 Protective Agents Phase 2
40 Adrenergic alpha-Antagonists Phase 2
41 Retinol palmitate Phase 2
42 retinol Phase 2
43 Adrenergic alpha-1 Receptor Antagonists Phase 2
44 Calcium, Dietary Phase 2
45 calcium channel blockers Phase 2
46 Antibodies Phase 1, Phase 2
47 Immunoglobulins, Intravenous Phase 1, Phase 2
48 Rho(D) Immune Globulin Phase 1, Phase 2
49 gamma-Globulins Phase 1, Phase 2
50 Immunologic Factors Phase 1, Phase 2

Interventional clinical trials:

(show top 50) (show all 65)
# Name Status NCT ID Phase Drugs
1 Propranolol for Syncope With Sympathoadrenal Imbalance Completed NCT00060866 Phase 4 Propranolol
2 The Effects of Bronchodilator Therapy On Respiratory and Autonomic Function in Patients With Familial Dysautonomia Completed NCT01987219 Phase 3 Albuterol-sulphate;Ipratropium-bromide
3 Carbidopa for the Treatment of Nausea and Vomiting in Familial Dysautonomia Completed NCT01212484 Phase 3 Carbidopa;Placebo
4 A Double-blind, Randomized, Placebo-controlled Trial to Evaluate the Efficacy of Intravenous Immunoglobulin Therapy in Autoimmune Autonomic Ganglionopathy. Completed NCT01522235 Phase 2, Phase 3 Double blinded IVIg
5 The Anti-inflammatory Effect of Vagus Nerve Stimulation (VNS): a New Approach in the Treatment of Crohn's Disease Terminated NCT01569503 Phase 3
6 Carbidopa in Familial Dysautonomia: Phase-II Study, Investigational New Drug (IND) 117435, Date: 01/07/13 Completed NCT02553265 Phase 2 Carbidopa Low Dose;Carbidopa High Dose
7 Verapamil as Adjunctive Seizure Therapy for Children and Young Adults With Dravet Syndrome Completed NCT01607073 Phase 2 Verapamil
8 The Nutritional Supplement Phosphatidylserine in Patients With Familial Recruiting NCT02276716 Phase 2 Phosphatidylserine
9 The Effect of Adrenergic Blocker Therapy on Cardiac and Striatal Transporter Uptake in Pre-Motor and Symptomatic Parkinson's Disease Recruiting NCT03775096 Phase 2 Carvedilol
10 IVIG (Gamunex-C) Study of Treatment for Autoimmune Neuropathic Dysautonomia/Postural Tachycardia (POTS) Enrolling by invitation NCT03919773 Phase 1, Phase 2 IVIG;Albumin
11 A Phase-2b, Double-Blind, Randomized Controlled Trial to Evaluate the Activity and Safety of Inebilizumab in Anti-Nmda Receptor Encephalitis and Assess Markers of Disease Not yet recruiting NCT04372615 Phase 2 Inebilizumab;Placebo
12 The Effects of Cannabidiol (CBD) on Electrical and Autonomic Cardiac Function in Children Terminated NCT02815540 Phase 1, Phase 2 Cannabidiol
13 Early Treatment of Paroxysmal Dysautonomia and Hypertonia for Severe Brain Injured Patients by Intrathecal Baclofen Therapy Terminated NCT00221689 Phase 2 baclofen (drug)
14 The Safety , Tolerability and Efficacy of Dronabinol, a Synthetic Endocannabinoid Receptor Agonist, for the Treatment of Nausea and Vomiting in Patients With Familial Dysautonomia Withdrawn NCT02608931 Phase 2 Dronabinol
15 Controlling Hyperadrenergic Activity in Neurologic Injury Withdrawn NCT01343329 Phase 1, Phase 2 Esmolol;Propranolol
16 The Safety and Tolerability of Kinetin, a Nutritional Supplement That Corrects the Splicing Defect, in Patients With Familial Dysautonomia Completed NCT02274051 Phase 1
17 Prospective Single-Arm Pilot Study for CT-Guided, Temporary Celiac Ganglion Block as a Test Before Celiac Ganglion Resection for Dysautonomia-Related Bowel Dysmotility Recruiting NCT04121338 Phase 1 Liposomal bupivacaine
18 Autonomic Cardiovascular Neuropathy in Recently Diagnosed DM2 Patients and in Pre-Diabetes Patients Unknown status NCT02931773
19 Brainstem Assesment in a Cohort of Very Preterm Babies (Less Than 28 Weeks) Unknown status NCT02669056
20 Glucose Tolerance in Patients With an Idiopathic Parkinson's Disease Unknown status NCT01114321
21 Anticipation Effect on Painful Phenomenons Linked to Rectal Distension for Patients With a Crohn's Disease in Remission: Functional MRI Study Unknown status NCT02874495
22 Prevalence and Mechanism of Palpitations and Tachycardia in Fibromyalgia Syndrome Unknown status NCT01147263
23 Study Title: Brain Transmitters/Metabolites, Magnetic Resonance Spectroscopy, and Brain Connectivity: Diagnostic Strategies to Study the Effects of Non-Pharmacologic Therapies for Dysautonomia and Chronic Nausea Completed NCT01692561
24 An Open-Label Pilot Trial of Cognitive Behavioral Therapy in Familial Dysautonomia Completed NCT03013777
25 Cardiac Autonomic Control in Children of HIV Positive Mothers Completed NCT00005353
26 Head Circumference Growth in Children With Ehlers-Danlos Syndrome Who Develop Dysautonomia ("POTS" -- Postural Orthostatic Tachycardia Syndrome)Later in Life -- a Retrospective Analysis Completed NCT01367977
27 Implementation of a Transdiagnostic Psychological Group Intervention for Pediatric Autonomic Dysfunction Completed NCT03185247
28 Haemodynamic and Pain Outcomes in Patients Undergoing Diabetic Foot Surgery Performed Under Sciatic Nerve Blocks With or Without Femoral Nerve Block Versus Spinal Anaesthesia Completed NCT02727348
29 Does Improving Vagal Tone Increase Mitochondrial Bioenergetics Completed NCT03931330
30 Tilt Table and Autonomic Testing in Suspected POTS Subjects Completed NCT01617616
31 Clinical Autonomic Disorders: A Training Protocol Completed NCT02154009
32 Blood Sampling for Neurochemical and Genetic Testing Completed NCT00001147
33 An Unicentric, Double-blind, Placebo Controlled, Phase IV Clinical Trial of Oral Melatonin Plus Zinc to Evaluate Relieving Self-reported Fatigue in CFS/ME Completed NCT03000777
34 Assessing the Outcomes of Web-based Pre-test Educational Module for Carrier Genetic Screening in Individuals of Ashkenazi Jewish Descent Completed NCT01999257
35 Study of Quality of Life After Aneurysmal Subarachnoid Hemorrhage in Patients Aged 70 Years or Older. Completed NCT00692744
36 Evaluation of Postoperative Pain by Spectral Analysis of ECG R-R Intervals Completed NCT00438035
37 PET Study of Biochemistry and Metabolism of the CNS: Parkinson Disease Completed NCT01565473
38 Clinical and Laboratory Evaluation of the Autonomic Nervous System in Primary Sjogren's Syndrome Completed NCT00565526
39 Attributional Style Assessment in Patients With Parkinson's Disease Treated With Deep Brain Stimulation Completed NCT03371277
40 Plasma Exchange for Autoimmune Autonomic Failure Completed NCT00359346
41 Clinical Laboratory Evaluation of Chronic Orthostatic Intolerance Completed NCT00069693
42 Relationship of Autonomic Function to Hypnotic Susceptibility Completed NCT00061009
43 The Brain Heart Interaction in Acute Stroke Completed NCT02734082
44 Pre-warming With Thermal Gown Prevents Maternal Hypothermia in Elective Cesarean Section Completed NCT02091466
45 The Pathogenesis of Idiopathic Dry Eyes Completed NCT01254201
46 Renal Arterial Denervation in Sympathetic Dysautonomia: RANSOM REGISTRY Recruiting NCT04314557
47 Testing for Dysautonomia in Patients Hospitalized for SARS-CoV-2 Infection (COVID-19) : COVIDANS Study Recruiting NCT04374045
48 Anomalies of Nocturnal Gaz Exchanges in Patients With Down Syndrome Aged From 4 to 16 Years Recruiting NCT03903666
49 PROSPECT ADDITION SCI - A PROSPECTive Study of Autonomic Dynamic Dysfunction to Predict infecTIONs After Spinal Cord Injury Recruiting NCT03253952
50 Natural History of Familial Dysautonomia Recruiting NCT03920774

Search NIH Clinical Center for Dysautonomia

Genetic Tests for Dysautonomia

Genetic tests related to Dysautonomia:

# Genetic test Affiliating Genes
1 Dysautonomia 29

Anatomical Context for Dysautonomia

MalaCards organs/tissues related to Dysautonomia:

40
Heart, Testes, Brain, Skin, Spinal Cord, Lung, Eye

Publications for Dysautonomia

Articles related to Dysautonomia:

(show top 50) (show all 2195)
# Title Authors PMID Year
1
Hyposmia in pure autonomic failure. 61 54
19433741 2009
2
Pupil abnormalities in selected autonomic neuropathies. 54 61
16966943 2006
3
[The most common dysautonomias]. 54 61
12577222 2003
4
Peripartum management of a patient with dopamine beta-hydroxylase deficiency, a rare congenital cause of dysautonomia. 61 54
12180590 2002
5
Gerstmann-Sträussler-Scheinker syndrome,fatal familial insomnia, and kuru: a review of these less common human transmissible spongiform encephalopathies. 61 54
11535002 2001
6
The sympathetic skin response in peripheral autonomic failure--evaluation in pure failure, pure cholinergic dysautonomia and dopamine-beta-hydroxylase deficiency. 54 61
9651662 1998
7
[Peripheral neuropathy and dysautonomia in a patient with primary Sjögren's syndrome]. 54 61
9884552 1998
8
Fatal familial insomnia with a mutation at codon 178 of the prion protein gene: first report from Japan. 54 61
8909448 1996
9
ROHHAD(NET) Syndrome: Systematic Review of the Clinical Timeline and Recommendations for Diagnosis and Prognosis. 61
32407531 2020
10
CASPR2 autoimmunity in children expanding to mild encephalopathy with hypertension. 61
32424051 2020
11
KIF1A-related disorders in children: A wide spectrum of central and peripheral nervous system involvement. 61
32096284 2020
12
Dysautonomia Is Linked to Striatal Dopamine Deficits and Regional Cerebral Perfusion in Early Parkinson Disease. 61
32520498 2020
13
Benign versus malignant Parkinson disease: the unexpected silver lining of motor complications. 61
32488298 2020
14
Dysautonomia in early Parkinson disease: a window into the determinants of functional disability and an opportunity for early intervention. 61
32361782 2020
15
Impact of a national genetic carrier-screening program for reproductive purposes. 61
32242916 2020
16
Mast cell biology in the context of dysautonomia and neuropathy. 61
32278086 2020
17
Comment on: 'Mast cell biology in the context of dysautonomia and neuropathy' by Dr. Nevio Cimolai. 61
32339670 2020
18
Meet the expert: How I treat chemotherapy-induced peripheral neuropathy. 61
32561202 2020
19
Expanding clinical spectrum of Caspr2 antibody-associated disease: warning on brainstem involvement and respiratory failure. 61
32371280 2020
20
Dysautonomia secondary to third ventriculostomy successfully managed with midodrine. 61
32554459 2020
21
Nelarabine-associated myelopathy in a patient with acute lymphoblastic leukaemia: Case report. 61
32517638 2020
22
Neurologic manifestations in hospitalized patients with COVID-19: The ALBACOVID registry. 61
32482845 2020
23
Severe dysautonomia as a manifestation of neurotoxicity after CAR-T cell therapy for diffuse large B-cell lymphoma. 61
32233094 2020
24
Progressive Vasoconstriction with Sequential Thermal Stimulation Indicates Vascular Dysautonomia in Sickle Cell Disease. 61
32518948 2020
25
Posterior reversible encephalopathy and Guillain-Barré syndrome: which came first, the chicken or the egg? A review of literature. 61
32506357 2020
26
Parkinson's disease: etiopathogenesis and treatment. 61
32576618 2020
27
Chronic unilateral cervical vagotomy reduces renal inflammation, blood pressure, and renal injury in a mouse model of lupus. 61
32538149 2020
28
Tossing and Turning in Bed: Nocturnal Movements in Parkinson's Disease. 61
32080891 2020
29
Subjects at risk of Parkinson's disease in health checkup examinees: cross-sectional analysis of baseline data of the NaT-PROBE study. 61
32030520 2020
30
Elbow proprioception is normal in patients with a congenital absence of functional muscle spindles. 61
32452029 2020
31
(H)Elping nerve growth factor: Elp1 inhibits TrkA's phosphatase to maintain retrograde signaling. 61
32281945 2020
32
Retrograde nerve growth factor signaling abnormalities in familial dysautonomia. 61
32281946 2020
33
Resection of hip heterotrophic ossification leads to resolution of autonomic nervous system dysfunction in a patient with spinal Charcot arthropathy: a case report. 61
32404876 2020
34
Assessment of Autonomic Nervous System in Children with Celiac Disease: A heart rate variability study. 61
32376794 2020
35
Cerebrovascular pathology and misdiagnosis of multiple system atrophy: An autopsy study. 61
32450546 2020
36
Complex syndromes of chronic pain, fatigue and cognitive impairment linked to autoimmune dysautonomia and small fiber neuropathy. 61
32171889 2020
37
Peripheral nerve pathology in VAPB-associated amyotrophic lateral sclerosis with dysautonomia in a Chinese family. 61
32383641 2020
38
Transient anisocoria after a traumatic cervical spinal cord injury: A case report. 61
30124383 2020
39
Sensory neuronopathy is a specific and disabling neurological manifestation of autoimmune hepatitis. 61
32441838 2020
40
SARS-CoV-2-associated Guillain-Barré syndrome with dysautonomia. 61
32445201 2020
41
Differences in clinical features between small fiber and sensitive large fiber neuropathies in Sjögren's syndrome. 61
32471733 2020
42
Mutation in the MICOS subunit gene APOO (MIC26) associated with an X-linked recessive mitochondrial myopathy, lactic acidosis, cognitive impairment and autistic features. 61
32439808 2020
43
Autonomic dysfunction in people with neuromyelitis optica spectrum disorders. 61
30887872 2020
44
Rhombencephalitis associated with isolated Zic4-antibodies in Paraneoplastic cerebellar degeneration: a case report. 61
32450842 2020
45
Heart Rate Variability Analysis: A Useful Tool to Assess Poststroke Cardiac Dysautonomia. 61
32358461 2020
46
Risk Factors for Falls in Patients with de novo Parkinson's Disease: A Focus on Motor and Non-Motor Symptoms. 61
32498497 2020
47
Characterization of recessive Parkinson's disease in a large multicenter study. 61
32472966 2020
48
Clinical characterization of patients with leucine-rich repeat kinase 2 genetic variants in Japan. 61
32398759 2020
49
Severe Cardiac Dysautonomia and Sudden Death in a Patient Presenting with Anginal Symptoms in Absence of Cardiovascular and Other Diseases: A Case Report. 61
32417866 2020
50
Hydrocephalus in Guillain barre syndrome: A case report and review of the literature. 61
32311917 2020

Variations for Dysautonomia

ClinVar genetic disease variations for Dysautonomia:

6 ‎‎ ‎‎ ‎‎ ‎‎ ‎‎
# Gene Name Type Significance ClinVarId dbSNP ID GRCh37 Pos GRCh38 Pos
1 CPT2 NM_000098.3(CPT2):c.149C>A (p.Pro50His)SNV Pathogenic 8954 rs28936375 1:53662764-53662764 1:53197092-53197092
2 USH2A NM_007123.5(USH2A):c.2299del (p.Glu767fs)deletion Pathogenic/Likely pathogenic 2351 rs80338903 1:216420437-216420437 1:216247095-216247095
3 46;XX;inv(14)(q24.1q32.1)dninversion Uncertain significance 267889
4 USH2A NM_206933.3(USH2A):c.5003G>T (p.Gly1668Val)SNV Uncertain significance 598989 rs1265349835 1:216258204-216258204 1:216084862-216084862
5 MYH8 NM_002472.3(MYH8):c.5743A>G (p.Ile1915Val)SNV Uncertain significance 598988 rs1216879928 17:10293842-10293842 17:10390525-10390525

Expression for Dysautonomia

Search GEO for disease gene expression data for Dysautonomia.

Pathways for Dysautonomia

GO Terms for Dysautonomia

Cellular components related to Dysautonomia according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 actin cytoskeleton GO:0015629 9.43 SNCA ACTL7B ACTL7A
2 inclusion body GO:0016234 9.16 SNCA PRNP
3 dynactin complex GO:0005869 8.96 ACTL7B ACTL7A
4 terminal bouton GO:0043195 8.8 USH2A SNCA PRNP

Biological processes related to Dysautonomia according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 negative regulation of neuron death GO:1901215 9.26 SNCA GBA
2 protein destabilization GO:0031648 9.16 SNCA PRNP
3 positive regulation of neuron death GO:1901216 8.96 SNCA PRNP
4 cellular response to copper ion GO:0071280 8.62 SNCA PRNP

Molecular functions related to Dysautonomia according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 copper ion binding GO:0005507 8.96 SNCA PRNP
2 cuprous ion binding GO:1903136 8.62 SNCA PRNP

Sources for Dysautonomia

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
53 NINDS
54 Novoseek
56 OMIM
57 OMIM via Orphanet
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 TGDB
70 Tocris
71 UMLS
72 UMLS via Orphanet
Content
Loading form....